DuChemBio announced plans to build a contract development and manufacturing (CDMO) plant for radiopharmaceuticals in Jeongeup, North Jeolla, with an investment of KRW 34.3 billion. Both announcements were made on the 7th, and details such as the plant’s specific scale and construction schedule are expected to be disclosed at a later date.
DuChemBio announced plans to build a radiopharmaceutical CDMO plant in the Jeongeup area of North Jeolla. The plant will be located in Jeongeup, North Jeolla, underscoring the company’s intention to strengthen its CDMO business.
The total investment is expected to amount to KRW 34.3 billion and will be allocated to the plant’s construction. The announcement did not include details such as the plant’s specific scale or completion schedule.
The matter was disclosed on the 7th, and the business is described as contract development and manufacturing (CDMO) for radiopharmaceuticals. Further information is expected to be released.